Pospíšilová Dagmar M.D., Ph.D.

Pospíšilová Dagmar M.D., Ph.D.'s picture
Phone: +420 588442798, +420 588444476

Publications (Impact Factor Journals):

  • [10]
    KARASKOVA, E., J. VOLEJNÍKOVÁ, D. HOLUB, M. VELGANOVA-VEGHOVA, L. SULOVSKÁ, V. MIHÁL, M. HORVÁTHOVÁ a D. POSPÍŠILOVÁ. Hepcidin in newly diagnosed inflammatory bowel disease in children. Journal of Paediatrics and Child Health. 2018, -, -. ISSN 1034-4810. IF: 3.595. PMID: 29923651
  • [9]
    MOJZIKOVA, R., P. KOŘALKOVÁ, D. HOLUB, Z. SAXOVA, D. POSPÍŠILOVÁ, D. PROCHAZKOVA, P. DŽUBÁK, M. HORVÁTHOVÁ a V. DIVOKÝ. Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin. Blood cells, molecules & diseases. 2017, 69, 23-29. ISSN 1079-9796. IF: 1.882. PMID: 28803808
  • [8]
    JAROSOVA, M., J. VOLEJNÍKOVÁ, I. PORIZKOVA, M. HOLZEROVA, D. POSPÍŠILOVÁ, Z. NOVÁK, J. VRBKOVÁ a V. MIHÁL. Chromosomal aberrations in childhood acute lymphoblastic leukemia: 15-year single center experience. Cancer Genetics. 2016, 209(7-8), 340-347. ISSN 2210-7762. IF: 1.930. PMID: 27341996
  • [7]
    VOLEJNÍKOVÁ, J., M. JAROSOVA, D. POSPÍŠILOVÁ, Z. NOVÁK, J. VRBKOVÁ, M. HAJDÚCH a V. MIHÁL. Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic. Neoplasma. 2016, 63(3), 456-61. ISSN 0028-2685. IF: 1.871. PMID: 26925793
  • [6]
    SULOVSKÁ, L., D. HOLUB, Z. ŽIDOVÁ, M. DIVOKÁ, M. HAJDÚCH, V. MIHÁL, J. VRBKOVÁ, M. HORVÁTHOVÁ a D. POSPÍŠILOVÁ. Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2015, 160(2), 231-237. ISSN 1213-8118 . IF: 0.924. PMID: 26592557
  • [5]
    POSPÍŠILOVÁ, D., D. HOLUB, Z. ŽIDOVÁ, L. SULOVSKÁ, J. HOUDA, V. MIHÁL, I. HADAČOVÁ, L. RADOVÁ, P. DŽUBÁK, M. HAJDÚCH, V. DIVOKÝ a M. HORVÁTHOVÁ. Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency. Haematologica. 2014, 99(7), e118-121. ISSN 0390-6078. IF: 5.814. PMID: 24727814
  • [4]
    MOJZIKOVA, R., P. KORALKOVA, D. HOLUB, Z. ŽIDOVÁ, D. POSPÍŠILOVÁ, J. CERMAK, Z.S. LALUHOVA, K. INDRAK, M. SUKOVA, M. PARTSCHOVA, J. KUCEROVA, M. HORVÁTHOVÁ a V. DIVOKÝ. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios. British Journal of Haematology. 2014, 165(4), 556-563. ISSN 0007-1048. IF: 4.971. PMID: 24533562
  • [3]
    SPENEROVA, M., P. DŽUBÁK, J. SROVNAL, L. RADOVÁ, R. BURIÁNOVÁ, P. KONEČNÝ, S. ŠÁLKOVÁ, Z. NOVÁK, D. POSPÍŠILOVÁ, J. STARÝ, B.. BLAZEK, J. HAK, T. VOTAVA, P. TIMR, E. KAISEROVA, E. BUBANSKA, V. MIHÁL a M. HAJDÚCH. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistence in acute childhood lymphoblastic leukemia. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2014, 158(3), 422-427. ISSN 1213-8118. IF: 1.200. PMID: 23128824
  • [2]
    JAROSOVA, M., M. HOLZEROVA, V. MIHÁL, I. LAKOMÁ, V. DIVOKÝ, B.. BLAZEK, D. POSPÍŠILOVÁ, M. HAJDÚCH, Z. NOVÁK, L. DUŠEK, J. KOPTÍKOVÁ, T. POULSEN a K. INDRAK. Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases. Cancer Genetics and Cytogenetics. 2003, 145(2), 161-168. ISSN 0165-4608. IF: 1.713. PMID: 12935929
  • [1]
    MIHÁL, V., M. HAJDÚCH, V. NOSKOVA, A. JANOŠŤÁKOVÁ, M. SAFAROVA, M. OREL, G. KUZMINA, B.. BLAZEK a D. POSPÍŠILOVÁ. The analysis od correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol. Bulletin du Cancer. 2004, 91(4), -. ISSN 0007-4551. IF: 0.654.

Publications (Other Reviewed Journals):

  • [3]
    HOLUB, D., J. HOUDA, M. HAJDÚCH, D. POSPÍŠILOVÁ a P. DŽUBÁK. Stanovení hladiny hepcidinu-25 v séru pomocí SPE_LC_MS/MS metody. Chemagazín. 2016, 5, 8-10. ISSN 1210-7409.
  • [2]
    HOUDA, J., P. DŽUBÁK, E. KARASKOVA, D. HOLUB, D. VYDRA, D. MLCUCHOVA, M. HAJDÚCH, O. POZLER a D. POSPÍŠILOVÁ. Výskyt anemie a význam měření hladiny hepcidinu metodou ELISA u dětí s nespecifickými střevními záněty. Česko-slovenská pediatrie. 2014, 69(3), 137-147. ISSN 0069-2328.
  • [1]
    POSPÍŠILOVÁ, D., J. HOUDA, D. HOLUB, B. LUDÍKOVÁ, R. MOJZIKOVA, P. POSPISILOVA, Z. ŽIDOVÁ, K. KAPRALOVA, M. HORVÁTHOVÁ, M. HAJDÚCH a P. DŽUBÁK. Význam stanovení hladiny hepcidinu v diagnostice vybraných typů anémií v dětském věku. Transfuze a hematologie dnes. 2012, 18(-), 58-65. ISSN 1213-5763.

Doctoral students mentor:

[2] Martina Divoká, 101/5000 Molecular-genetic characterization of thalassemia and hemoglobin variants in the Czech and Slovak population,
Ph.D. specialization: Pediatrics, status: Graduated, from: 2012 to 2016
[1] Lucie Sulovská, The importance of hepcidin testing in selected congenital anemias in childhood and in blood donors,
Ph.D. specialization: Pediatrics, status: Graduated, from: 2012 to 2016